Farr Miller & Washington’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $3.11M | Sell |
41,419
-256
| -0.6% | -$19.5K | 0.2% | 55 |
|
|
2021
Q2 | $3.24M | Buy |
41,675
+20
| +0% | +$1.49K | 0.21% | 55 |
|
|
2021
Q1 | $3.06M | Buy |
41,655
+1,379
| +3% | +$102K | 0.22% | 53 |
|
|
2020
Q4 | $3.14M | Buy |
40,276
+2,164
| +6% | +$166K | 0.24% | 49 |
|
|
2020
Q3 | $3.02M | Buy |
38,112
+28,134
| +282% | +$2.2M | 0.26% | 46 |
|
|
2020
Q2 | $736K | Buy |
9,978
+262
| +3% | +$19.7K | 0.06% | 91 |
|
|
2020
Q1 | $713K | Buy |
9,716
+131
| +1% | +$10.3K | 0.07% | 81 |
|
|
2019
Q4 | $832K | Buy |
9,585
+189
| +2% | +$15.5K | 0.06% | 86 |
|
|
2019
Q3 | $755K | Buy |
9,396
+63
| +0.7% | +$5.05K | 0.06% | 85 |
|
|
2019
Q2 | $747K | Sell |
9,333
-1,048
| -10% | -$80.2K | 0.06% | 77 |
|
|
2019
Q1 | $824K | Hold |
10,381
| – | – | 0.07% | 71 |
|
|
2018
Q4 | $757K | Sell |
10,381
-2,024
| -16% | -$143K | 0.07% | 72 |
|
|
2018
Q3 | $840K | Hold |
12,405
| – | – | 0.07% | 71 |
|
|
2018
Q2 | $719K | Sell |
12,405
-1,108
| -8% | -$62.5K | 0.07% | 72 |
|
|
2018
Q1 | $702K | Buy |
13,513
+472
| +4% | +$25.5K | 0.07% | 77 |
|
|
2017
Q4 | $700K | Sell |
13,041
-923
| -7% | -$51.2K | 0.06% | 77 |
|
|
2017
Q3 | $853K | Buy |
13,964
+105
| +0.8% | +$6.37K | 0.08% | 70 |
|
|
2017
Q2 | $848K | Buy |
13,859
+402
| +3% | +$24.5K | 0.08% | 68 |
|
|
2017
Q1 | $816K | Buy |
13,457
+157
| +1% | +$9.53K | 0.08% | 64 |
|
|
2016
Q4 | $747K | Sell |
13,300
-807
| -6% | -$47.2K | 0.08% | 68 |
|
|
2016
Q3 | $840K | Sell |
14,107
-970
| -6% | -$56.7K | 0.09% | 66 |
|
|
2016
Q2 | $829K | Buy |
15,077
+2,822
| +23% | +$150K | 0.09% | 67 |
|
|
2016
Q1 | $619K | Buy |
12,255
+450
| +4% | +$22K | 0.07% | 72 |
|
|
2015
Q4 | $595K | Hold |
11,805
| – | – | 0.07% | 70 |
|
|
2015
Q3 | $556K | Sell |
11,805
-1,362
| -10% | -$72.4K | 0.07% | 73 |
|
|
2015
Q2 | $715K | Sell |
13,167
-2,229
| -14% | -$125K | 0.08% | 70 |
|
|
2015
Q1 | $844K | Hold |
15,396
| – | – | 0.1% | 63 |
|
|
2014
Q4 | $834K | Sell |
15,396
-210
| -1% | -$11.7K | 0.1% | 66 |
|
|
2014
Q3 | $883K | Sell |
15,606
-602
| -4% | -$33.8K | 0.11% | 63 |
|
|
2014
Q2 | $895K | Hold |
16,208
| – | – | 0.11% | 64 |
|
|
2014
Q1 | $878K | Buy |
16,208
+1,917
| +13% | +$99.3K | 0.12% | 62 |
|
|
2013
Q4 | $682K | Buy |
14,291
+1,048
| +8% | +$47.9K | 0.09% | 64 |
|
|
2013
Q3 | $602K | Sell |
13,243
-235
| -2% | -$10.7K | 0.1% | 64 |
|
|
2013
Q2 | $597K | Buy |
+13,478
| New | +$602K | 0.1% | 64 |
|
Other funds holding MRK
Farr Miller & Washington's MRK Position: Q3 2021 in Review
Farr Miller & Washington reduced its Merck (MRK) stake by 0.61% in Q3 2021, selling an estimated $19.5K and leaving 41,419 shares worth $3.11M. The position accounts for 0.2% of the portfolio, ranked #55.
Farr Miller & Washington first reported a position in MRK in Q2 2013 and has held it in 34 quarters since. The position peaked at $3.24M in Q2 2021. 2,647 funds tracked by Wall St. Rank hold MRK as of Q3 2021.
- Farr Miller & Washington held 41,419 shares of Merck worth $3.11M as of Q3 2021.
- Farr Miller & Washington sold 256 Merck shares in Q3 2021, an estimated $19.5K.
- Merck made up 0.2% of Farr Miller & Washington's portfolio in Q3 2021, its #55 holding.
- Farr Miller & Washington first reported a position in Merck in Q2 2013 and has held it in 34 quarters since.
- Farr Miller & Washington's Merck position peaked at $3.24M in Q2 2021.
- 2,647 funds tracked by Wall St. Rank held Merck as of Q3 2021.
Based on Farr Miller & Washington's 13F filing for Q3 2021, filed 15 Nov 2021.